Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
DoAI Inc. logo — Pioneering new paradigm and building ready-made medical AI m...

DoAI Inc.

Pioneering new paradigm and building ready-made medical AI models

Founded 2018 Korea South Korea South 3 employees Seed Total: $4.30B Biotechnology

General Information

Company Name DoAI Inc.
Founded Year 2018
Location Korea South Korea South +1
Employees 3
Industries Biotechnology
Funding Stage Seed
Social

Get notified when DoAI Inc. moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About DoAI Inc.

DoAI Inc. is a biotechnology startup based in South Korea, founded in 2018. The company's slogan, "Pioneering new paradigm and building ready-made medical AI models," reflects its dedication to developing AI-powered early-stage cancer diagnostic solutions with a specific focus on pancreatic cancer diagnosis. Utilizing Nano-Raman & AI technology, DoAI aims to provide affordable and effective healthcare benefits for everyone. In August 2020, DoAI secured a KRW1.50B Seed Round investment from VentureSquare and the Korea Credit Guarantee Fund. The company's vision is to become the leading AI-enabled medical solution provider and an accelerator of predictive, preventive, personalized, and particularized health practice for patients. With its innovative approach and strategic investments, DoAI Inc. is strategically positioned to make significant strides in the biotechnology space, particularly in the realm of AI-powered medical solutions.

Taxonomy: AI-powered medical diagnostics, cancer diagnosis, early cancer detection, Nano-Raman technology, predictive medicine, personalized healthcare, radiology AI, pathology AI, drug discovery AI, genomics AI, deep learning, SERS technology

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round •••••• 2
Investor Investor
06 Aug 2020
Seed Round •••••• 1 •••• •••• 31 Jan 2020
Seed Round •••••• 1 •••• •••• 01 Sep 2019

DoAI Inc. Alternatives & Competitors

DoAI Inc. vs
NanoCube
NanoCube Australia

Transforming cancer diagnostics and treatment with bioinspired nanorobotics

2 employees
DoAI Inc. vs
Reccan AB
Reccan AB Sweden

A breakthrough in the detection of pancreatic cancer

Series Unknown
3 employees
Health Care
DoAI Inc. vs
Cianna Medical
Cianna Medical

Pioneering Women's Health: Advancing Breast Conservation Therapy for Early-Stage Breast Cancer

Series Unknown
Health Care, Medical Devices
Compare DoAI Inc. vs Cianna Medical

FAQ About DoAI Inc.

Pioneering new paradigm and building ready-made medical AI models
DoAI Inc. was founded in 2018.
DoAI Inc. is headquartered in Korea South.
DoAI Inc. operates in the following industries: Biotechnology.
DoAI Inc. has approximately 3 employees.
DoAI Inc. has completed 3 funding rounds, raising a total of $4.30B. The latest funding stage is Seed.
Top alternatives and competitors to DoAI Inc. include NanoCube, Reccan AB, Cianna Medical, Atossa Therapeutics, The Wistar Institute. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
DoAI Inc. and NanoCube are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors DoAI Inc. and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy